These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18441686)

  • 1. [Current features of antibacterial therapy of nosocomial pneumonia].
    Baĭgozina EA; Sovalkin VI
    Ter Arkh; 2008; 80(3):59-62. PubMed ID: 18441686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of clinical features and outcome of nosocomial pneumonia caused by Pseudomonas aeruginosa].
    Baĭgozina EA
    Klin Med (Mosk); 2009; 87(6):57-9. PubMed ID: 19670720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy.
    Lee SC; Hua CC; Yu TJ; Shieh WB; See LC
    Int J Clin Pract; 2005 Jan; 59(1):39-45. PubMed ID: 15707463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registration trials of antibacterial drugs for the treatment of nosocomial pneumonia.
    Sorbello A; Komo S; Valappil T; Nambiar S
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S36-41. PubMed ID: 20597669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Furtado GH; d'Azevedo PA; Santos AF; Gales AC; Pignatari AC; Medeiros EA
    Int J Antimicrob Agents; 2007 Oct; 30(4):315-9. PubMed ID: 17631984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognosis of nosocomial pneumonia outcome].
    Sidorova LD; Domnikova NP
    Ter Arkh; 1999; 71(12):37-40. PubMed ID: 10647199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures.
    Herer B; Fuhrman C; Gazevic Z; Cabrit R; Chouaïd C
    Clin Microbiol Infect; 2009 Feb; 15(2):165-72. PubMed ID: 19154492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: a prospective observational study.
    Alvarez-Lerma F; Alvarez B; Luque P; Ruiz F; Dominguez-Roldan JM; Quintana E; Sanz-Rodriguez C;
    Crit Care; 2006; 10(3):R78. PubMed ID: 16704742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of nosocomial pneumonia.
    Bonten MJ; Stobberingh EE
    Br J Hosp Med; 1995 Oct 4-17; 54(7):335-40. PubMed ID: 8556213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for nosocomial pneumonia due to MRSA.
    Niederman MS
    J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
    Wakino S; Imai E; Yoshioka K; Kamayachi T; Minakuchi H; Hayashi K; Inamoto H; Itoh H
    Ther Apher Dial; 2009 Jun; 13(3):193-8. PubMed ID: 19527465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management.
    Tacconelli E; De Angelis G
    Curr Opin Pulm Med; 2009 May; 15(3):218-22. PubMed ID: 19373090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of late-onset hospital-acquired pneumonia related to causative organism.
    McClure JR; Cooke RP; Lal P; Pickles D; Majjid S; Grant CA; Jones TM; Dempsey GA
    J Hosp Infect; 2009 Apr; 71(4):348-52. PubMed ID: 19157643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Rubinstein E; Kollef MH; Nathwani D
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S378-85. PubMed ID: 18462093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Some problems of the current therapy of infective endocarditis].
    Butkevich OM; Vinogradova TL
    Ter Arkh; 2000; 72(9):54-7. PubMed ID: 11076419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the clinical and pharmacoeconomic efficiency of treatment in patients with community-acquired pneumonia with third-generation cephalosporins].
    Starodubtseva OI; Vakhrushev IaM
    Probl Tuberk Bolezn Legk; 2009; (6):28-9. PubMed ID: 19642570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes.
    Lancaster JW; Lawrence KR; Fong JJ; Doron SI; Garpestad E; Nasraway SA; Devlin JW
    Pharmacotherapy; 2008 Jul; 28(7):852-62. PubMed ID: 18576900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.